Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 2, 2008, Pages 285-290

  Fujimori, Keita ^a   Oh I, Keiko ^a   Takeuchi, Masaru ^a   Yamakawa, Naoyuki ^a   Hattori, Takaaki ^a   Kezuka, Takeshi ^a   Keino, Hiroshi ^a   Suzuki, Jun ^a   Goto, Hiroshi ^a   Sakai, Jun ichi ^a   Usui, Masahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Granulocyte; Uveitis

Indexed keywords

COLCHICINE; CYCLOSPORIN; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; METHOTREXATE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; APOPTOSIS; ARTICLE; BEHCET DISEASE; BLOOD CELL; CELL ASSAY; CELL STIMULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REMISSION; UVEITIS;

ADULT; ANNEXIN A5; ANTIGENS, CD95; APOPTOSIS; BEHCET SYNDROME; CELL CULTURE TECHNIQUES; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS, ANTERIOR;

EID: 38549123916     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0659-5     Document Type: Article

References (31)

1. Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Ciccia F, Giardina E, Triolo G (2000) Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behcet's disease. Clin Exp Rheumatol 18:495-498
2. Akdeniz N, Esrefoglu M, Keles MS, Karakuzu A, Atasoy M (2004) Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore 33:596-599
3. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020
4. Direskeneli H (2001) Behcet's disease: Infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996-1002
5. Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T (2001) Neutrophil activation in Behcet's disease. Clin Exp Rheumatol 19:S19-S24
6. Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm 11:87-93
7. Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm 11:87-93
8. Gorman AM, Zhivotovsky B, Orrenius S, Ceccatellis S (1999) Cytochrome c release and caspase-3 activation during colchicine-induced apoptosis of cerebellar granule cells. Eur J Neurosci 11:1067-1072
9. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192
10. Hachiya O, Takeda Y, Miyata H, Watanabe H, Yamashita T, Sendo F (1995) Inhibition by bacterial lipopolysaccharide of spontaneous and TNF-alpha-induced human neutrophil apoptosis in vitro. Microbiol Immunol 39:715-723
11. Homburg CH, Roos D (1996) Apoptosis of neutrophils. Curr Opin Hematol 3:94-99
12. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
13. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 3:738-743
14. Liles WC, Klebanoff SJ (1995) Regulation of apoptosis in neutrophils - Fas track to death? J Immunol 155:3289-3291
15. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429-440
16. Ogawa T (1995) Neutrophil chemotaxis by polarization assay in Behcet's disease and sarcoidosis. Nippon Ganka Gakkai Zasshi 99:696-702
17. Qiao H, Sonoda KH, Ariyama A, Kuratomi Y, Kawano Y, Ishibashi T (2005) CXCR2 Expression on neutrophils is upregulated during the relapsing phase of ocular Behcet disease. Curr Eye Res 30:195-203
18. Saga T, Matsuda H (1985) Microtubules in neutrophils of patients with Behcet's disease. Jpn J Ophthalmol 29:31-36
19. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S (1996) Cytokines in Behcet's disease. J Rheumatol 23:321-322
20. Shimada K, Yaoita H, Shikano S (1971) Chemotactic activity for polymorphonuclear leucocytes of the aqueous humor in patients with Behcet's disease. Nippon Ganka Gakkai Zasshi 75:2100-2105
21. Smith JR, Hart PH, Standfield SD, Coster DJ, Wing SJ, Williams KA (2000) Apoptosis is a prominent feature of acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol 84:205-211
22. Sobel JD, Haim S, Obedeanu N, Meshulam T, Merzbach D (1977) Polymorphonuclear leucocyte function in Behcet's disease. J Clin Pathol 30:250-253
23. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99:396-402
24. Takeuchi A, Kobayashi K, Mori M, Hashimoto A (1986) Non-phagocytic beta-glucuronidase release in Behcet's disease. Clin Exp Rheumatol 4:3-7
25. Tanaka T, Yamakawa N, Koike J, Suzuki F, Ususi M (1999) Behcet's disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm 7:69-74
26. Ureten K, Ertenli I, Ozturk MA, Kiraz S, Onat AM, Tuncer M, Okur H, Akdogan A, Apras S, Calguneri M (2005) Neutrophil CD64 expression in Behcet's disease. J Rheumatol 32:849-852
27. Yamada M, Murai Y, Mimura Y (1980) Neutrophil beta-glucuronidase activity in Behcet's disease (author's translation). Nippon Ganka Gakkai Zasshi 84:1099-1106
28. Yamagami S, Kawashima H, Tsuru T, Yamagami H, Kayagaki N, Yagita H, Okumura K, Gregerson DS (1997) Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64:1107-1111
29. Yamashita S, Suzuki A, Yanagita T, Hirohata S, Kamada M, Toyoshima S (2000) Analysis of neutrophil proteins of patients with Behcet's disease by two-dimensional gel electrophoresis. Biol Pharm Bull 23:519-522
30. Yoshida T, Tanaka M, Sotomatsu A, Okamoto K, Hirai S (1998) Serum of Behcet's disease enhances superoxide production of normal neutrophils. Free Radic Res 28:39-44
31. Zouboulis C, May T (2003) Pathogenesis of Adamantiades-Behcet's disease. Adv Exp Med Biol 528:161-171